COVID-19 and Molecular Genetics
Deadline for manuscript submissions: closed (20 May 2021) | Viewed by 35422
Interests: human genetics; laminopathies; gene therapy; genomics; pharmacogenomics
With 31,926,175 confirmed cases; 977,357 deaths (3.1%); and 22,004,598 recovered (68.9%) (Sept 24, 2020), COVID-19 is currently the number one challenge for human health worldwide. The COVID-19 pandemic wave has generated many urgent questions about the origin, trajectory, tissue/host variance, and the different clinical manifestations of the causative agent SARS-CoV-2. This Special Issue of Genes will focus on examining genetic/genomic variations, pathogenic mechanisms, clinical manifestations, and epidemiological and ethical aspects of the host. Research papers addressing the identification of genetic and epigenetic factors that confer susceptibility or resistance to viral infections and increase the risk of life-threatening complications will be welcomed.
The overall objective of the Special Issue is to contribute to scientific knowledge through the identification of actionable biomarkers to improve diagnosis and management, predict clinical and immunological outcomes, and accelerate the development of new treatments.
Prof. Dr. Giuseppe Novelli
Prof. Dr. Michela Biancolella
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Genomic biomarkers
- Genetic susceptibility
- Genetic resistors
- Viral accommodation